APPLICATION
ANDA075241
TYPE
ANDA
ORIGINAL APPROVAL
1999-05-28
LATEST ACTION
2025-09-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
FUROSEMIDEPrescription
FUROSEMIDE 10MG/ML · INJECTABLE · INJECTION
Approval history
2025-09-12Labeling · Supplement 23 · standardAP
2022-12-05Labeling · Supplement 16 · standardAP
2022-12-05Labeling · Supplement 15 · standardAP
2012-05-10Labeling · Supplement 12 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.